Literature DB >> 11538739

Mechanisms of post-flight orthostatic intolerance.

C G Blomqvist1, J C Buckey, F A Gaffney, L D Lane, B D Levine, D E Watenpaugh.   

Abstract

Post-flight orthostatic intolerance is a dramatic physiological consequence of human adaptation to microgravity made inappropriate by a sudden return to 1-G. The immediate mechanism is almost always a failure to maintain adequate tissue perfusion, specifically perfusion of the central nervous system, but vestibular dysfunction may occasionally be the primary cause. Orthostatic intolerance is present in a wide range of clinical disorders of the nervous and cardiovascular systems. The intolerance that is produced by spaceflight and 1-G analogs (bed rest, head-down tilt at a moderate angle, water immersion) is different from its clinical counterparts by being only transiently present in subjects who otherwise have normal cardiovascular and regulatory systems. However, the same set of basic pathophysiological elements should be considered in the analysis of any form of orthostatic intolerance.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; NASA Discipline Number 00-00; NASA Program Flight; Non-NASA Center

Mesh:

Substances:

Year:  1994        PMID: 11538739

Source DB:  PubMed          Journal:  J Gravit Physiol        ISSN: 1077-9248


  18 in total

1.  NAD(P)H oxidase inhibiting with apocynin improved vascular reactivity in tail-suspended hindlimb unweighting rat.

Authors:  Ran Zhang; Hai-hong Ran; Jin Ma; Yun-gang Bai; Le-jian Lin
Journal:  J Physiol Biochem       Date:  2011-10-21       Impact factor: 4.158

2.  Artificial gravity with ergometric exercise can prevent enhancement of popliteal vein compliance due to 4-day head-down bed rest.

Authors:  Yong-Jie Yao; Yong-Sheng Zhu; Chang-Bin Yang; Xiao-Dong Zhou; Xi-Qing Sun
Journal:  Eur J Appl Physiol       Date:  2011-07-24       Impact factor: 3.078

Review 3.  Region-specific vascular remodeling and its prevention by artificial gravity in weightless environment.

Authors:  Li-Fan Zhang
Journal:  Eur J Appl Physiol       Date:  2013-03-24       Impact factor: 3.078

4.  Noisy fluctuation of heart rate indicates cardiovascular system instability.

Authors:  Jacques-Olivier Fortrat; Charlotte Baum; Christian Jeanguillaume; Marc-Antoine Custaud
Journal:  Eur J Appl Physiol       Date:  2013-05-08       Impact factor: 3.078

Review 5.  Adolescent fatigue, POTS, and recovery: a guide for clinicians.

Authors:  Sarah J Kizilbash; Shelley P Ahrens; Barbara K Bruce; Gisela Chelimsky; Sherilyn W Driscoll; Cynthia Harbeck-Weber; Robin M Lloyd; Kenneth J Mack; Dawn E Nelson; Nelly Ninis; Paolo T Pianosi; Julian M Stewart; Karen E Weiss; Philip R Fischer
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2014 May-Jun

Review 6.  Orthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.

Authors:  Michael Gutkin; Julian M Stewart
Journal:  Am J Hypertens       Date:  2016-04-01       Impact factor: 2.689

Review 7.  Pediatric Disorders of Orthostatic Intolerance.

Authors:  Julian M Stewart; Jeffrey R Boris; Gisela Chelimsky; Phillip R Fischer; John E Fortunato; Blair P Grubb; Geoffrey L Heyer; Imad T Jarjour; Marvin S Medow; Mohammed T Numan; Paolo T Pianosi; Wolfgang Singer; Sally Tarbell; Thomas C Chelimsky
Journal:  Pediatrics       Date:  2017-12-08       Impact factor: 7.124

8.  Skin surface cooling improves orthostatic tolerance following prolonged head-down bed rest.

Authors:  David M Keller; David A Low; Scott L Davis; Jeff Hastings; Craig G Crandall
Journal:  J Appl Physiol (1985)       Date:  2011-03-31

Review 9.  Common syndromes of orthostatic intolerance.

Authors:  Julian M Stewart
Journal:  Pediatrics       Date:  2013-04-08       Impact factor: 7.124

10.  The Mice Drawer System (MDS) experiment and the space endurance record-breaking mice.

Authors:  Ranieri Cancedda; Yi Liu; Alessandra Ruggiu; Sara Tavella; Roberta Biticchi; Daniela Santucci; Silvia Schwartz; Paolo Ciparelli; Giancarlo Falcetti; Chiara Tenconi; Vittorio Cotronei; Salvatore Pignataro
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.